Valuation: Embracing Future Holdings Limited

Market Cap 57.2M 44.74M 38.64M 36.36M 33.05M 62.15M 4.29B 63.07M 427M 167M 2.14B 168M 164M 7.14B P/E 2024
-8.18x
P/E 2025 -22.5x
Enterprise Value 59.06M 46.2M 39.9M 37.54M 34.12M 64.17M 4.43B 65.11M 440M 173M 2.21B 173M 170M 7.37B EV / Sales 2024
58.8x
EV / Sales 2025 17.5x
Free-Float
44.94%
Yield 2024 *
-
Yield 2025 -
1 week-15.38%
Current month-5.71%
1 month-17.50%
3 months-26.67%
6 months-54.17%
Current year-36.54%
1 week 0.03
Extreme 0.032
0.04
1 month 0.03
Extreme 0.032
0.04
Current year 0.03
Extreme 0.032
0.09
1 year 0.02
Extreme 0.021
0.09
3 years 0.01
Extreme 0.008
0.09
5 years 0.01
Extreme 0.008
0.26
10 years 0.01
Extreme 0.008
0.88
Manager TitleAgeSince
President 46 2024-04-29
Comptroller/Controller/Auditor 44 2024-06-30
Corporate Secretary - -
Director TitleAgeSince
Director/Board Member 64 2021-06-13
Director/Board Member 55 2023-03-30
Director/Board Member 70 2023-11-26
Date Insider Type Main position Quantity % Market Cap.
4/30/21 Fiscal year

Chairman

330,000 0.1250%
8/19/20 Free

Chairman

1,130,000 0.4340%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-15.38%+50.00%+120.00% 44.74M
+4.43%+1.73%+23.11%+15.25% 218B
+5.66%+1.74%-1.33%-16.31% 140B
+2.30%-0.11%-16.36%+39.82% 138B
+3.13%+1.30%-49.79%+3.31% 73.14B
+1.68%-0.29%+17.55%+21.55% 52.44B
+1.33%+2.51%-16.09%-12.03% 50.85B
+4.00%+3.53%+27.77%+29.12% 41.92B
+3.98%-0.40%+39.23%+55.15% 39.42B
+3.03%+3.56%+1.19%+8.53% 32.81B
Average +2.96%-1.77%+7.53%+26.44% 78.69B
Weighted average by Cap. +3.66%-2.40%+2.29%+13.95%

Financials

2024 2025
Net sales 858K 671K 580K 545K 496K 932K 64.3M 946K 6.4M 2.51M 32.16M 2.52M 2.46M 107M 5.26M 4.12M 3.55M 3.34M 3.04M 5.72M 394M 5.8M 39.23M 15.37M 197M 15.45M 15.11M 657M
Net income -3.43M -2.69M -2.32M -2.18M -1.98M -3.73M -257M -3.79M -25.6M -10.03M -129M -10.08M -9.87M -429M -3.96M -3.1M -2.68M -2.52M -2.29M -4.3M -297M -4.37M -29.54M -11.58M -149M -11.64M -11.38M -495M
Net Debt 1.46M 1.14M 983K 925K 841K 1.58M 109M 1.6M 10.85M 4.25M 54.54M 4.27M 4.18M 182M 1.86M 1.45M 1.25M 1.18M 1.07M 2.02M 139M 2.05M 13.84M 5.42M 69.57M 5.45M 5.33M 232M
Logo Embracing Future Holdings Limited
Biolidics Limited is a Singapore-based precision medicine medical technology company. The Company's principal activities are technology development, technology transfer, selling and distribution of biomedical technology, life and medicine science related products and services; provision of laboratory services and investment holding. Its segments are Cancer, Infectious diseases, and Laboratory services, and Corporate segments. Its Cancer and infectious diseases segments involve the identifying and assessing potential collaboration partners, technology, products and services, product development, innovation and improvement and the management of global distributorship networks and direct customers in the cancer field, and the infectious diseases field. The Laboratory services segment involves the business, operation, and provision of laboratory services to customers. The laboratory has regulatory approval from Singapore’s Ministry of Health for testing for COVID-19 in Singapore.
Employees
-
Date Price Change Volume
26-08-19 SGD 0.0330 0.00% 13,000
26-08-18 SGD 0.0330 -2.94% 453,700
26-08-17 SGD 0.0340 -2.86% 446,200
26-08-14 SGD 0.0350 +2.94% 200,000
26-08-13 SGD 0.0340 -12.82% 600